Journal article

Investigation of bias related to differences between case and control interview dates in five INTERPHONE countries

Michelle C Turner, Siegal Sadetzki, Chelsea E Langer, Rodrigo Villegas, Jordi Figuerola, Bruce K Armstrong, Angela Chetrit, Graham G Giles, Daniel Krewski, Martine Hours, Mary L McBride, Marie-Elise Parent, Lesley Richardson, Jack Siemiatycki, Alistair Woodward, Elisabeth Cardis

Annals of Epidemiology | ELSEVIER SCIENCE INC | Published : 2016

Grants

Awarded by European Fifth Framework Program, "Quality of Life and Management of Living Resources"


Awarded by National Health and Medical Research Council (EME)


Awarded by Canadian Institutes of Health Research (CIHR)


Awarded by l'Association pour la Recherche sur le Cancer (ARC)


Funding Acknowledgements

Funding for the INTERPHONE Study was provided by the European Fifth Framework Program, "Quality of Life and Management of Living Resources" (contract QLK4-CT-1999901563), and the International Union against Cancer (UICC). The UICC received funds for this purpose from the Mobile Manufacturers' Forum and GSM Association. Provision of funds to the INTERPHONE Study investigators via the UICC was governed by agreements that guaranteed INTERPHONE's complete scientific independence. The terms of these agreements are publicly available at http://www.iarc.fr/en/research-groups/RAD/RCAd.html. The Australian center was supported by the National Health and Medical Research Council (EME grant 219129); B.K.A. was supported by a University of Sydney Medical Foundation Program Grant. The Cancer Council NSW and the Cancer Council Victoria provided most of the infrastructure for the project in Australia. The Canada Montreal data collection was funded by a grant from the Canadian Institutes of Health Research (CIHR; project MOP-42525). Additionally, J.S.'s research team was partly funded by the Canada Research Chair programme and by the Guzzo-CRS Chair in Environment and Cancer. The other Canadian centers were supported by a university-industry partnership grant from the CIHR, the latter including partial support from the Canadian Wireless Telecommunications Association. The CIHR university-industry partnerships program also includes provisions that ensure complete scientific independence of the investigators. D.K. received grant support from the Natural Sciences and Engineering Research Council of Canada as holder of the Industrial Research Chair in Risk Science, which is funded by a peer-reviewed university-industry partnership research chair program; he also serves as Chief Risk Scientist for Risk Sciences International, a Canadian company established in partnership with the University of Ottawa. Additional funding for the study in France was provided by l'Association pour la Recherche sur le Cancer (ARC; contract 5142) and three network operators (Orange, SFR, Bouygues Telecom). The funds provided by the operators represented 5% of the total cost of the French study and were governed by contracts guaranteeing the complete scientific independence of the investigators. In New Zealand, funding was provided by the Health Research Council, Hawkes Bay Medical Research Foundation, and the Cancer Society of New Zealand. M.C.T. was funded by a Government of Canada Banting Postdoctoral Fellowship.